Clinical Trial Update: Added Value of Gadoxetic Acid-enhanced Liver MRI

View source ↗

Summary

A completed clinical trial evaluating the added diagnostic value of gadoxetic acid-enhanced liver MRI for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• EOVIST (GADOXETATE DISODIUM)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hcc, Diagnosis | Status: COMPLETED